Oxidative DNA Damage and Cisplatin Neurotoxicity Is Exacerbated by Inhibition of OGG1 Glycosylase Activity and APE1 Endonuclease Activity in Sensory Neurons

Cisplatin can induce peripheral neuropathy, which is a common complication of anti-cancer treatment and negatively impacts cancer survivors during and after completion of treatment; therefore, the mechanisms by which cisplatin alters sensory neuronal function to elicit neuropathy are the subject of...

Full description

Bibliographic Details
Main Authors: Adib Behrouzi, Hanyu Xia, Eric L. Thompson, Mark R. Kelley, Jill C. Fehrenbacher
Format: Article
Language:English
Published: MDPI AG 2022-02-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/23/3/1909
_version_ 1797487078044336128
author Adib Behrouzi
Hanyu Xia
Eric L. Thompson
Mark R. Kelley
Jill C. Fehrenbacher
author_facet Adib Behrouzi
Hanyu Xia
Eric L. Thompson
Mark R. Kelley
Jill C. Fehrenbacher
author_sort Adib Behrouzi
collection DOAJ
description Cisplatin can induce peripheral neuropathy, which is a common complication of anti-cancer treatment and negatively impacts cancer survivors during and after completion of treatment; therefore, the mechanisms by which cisplatin alters sensory neuronal function to elicit neuropathy are the subject of much investigation. Our previous work suggests that the DNA repair activity of APE1/Ref-1, the rate-limiting enzyme of the base excision repair (BER) pathway, is critical for neuroprotection against cisplatin. A specific role for 8-oxoguanine DNA glycosylase-1 (OGG1), the glycosylase that removes the most common oxidative DNA lesion, and putative coordination of OGG1 with APE1/Ref-1 in sensory neurons, has not been investigated. We investigated whether inhibiting OGG1 glycosylase activity with the small molecule inhibitor, TH5487, and/or APE1/Ref-1 endonuclease activity with APE Repair Inhibitor III would alter the neurotoxic effects of cisplatin in sensory neuronal cultures. Sensory neuron function was assessed by calcitonin gene-related peptide (CGRP) release, as a marker of sensitivity and by neurite outgrowth. Cisplatin altered neuropeptide release in an inverse U-shaped fashion, with low concentrations enhancing and higher concentrations diminishing CGRP release. Pretreatment with BER inhibitors exacerbated the functional effects of cisplatin and enhanced 8oxo-dG and adduct lesions in the presence of cisplatin. Our studies demonstrate that inhibition of OGG1 and APE1 endonuclease activity enhances oxidative DNA damage and exacerbates neurotoxicity, thus limiting oxidative DNA damage in sensory neurons that might alleviate cisplatin-induced neuropathy.
first_indexed 2024-03-09T23:42:36Z
format Article
id doaj.art-1dcf4214466d44149cb493c6f4abd937
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-09T23:42:36Z
publishDate 2022-02-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-1dcf4214466d44149cb493c6f4abd9372023-11-23T16:48:37ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672022-02-01233190910.3390/ijms23031909Oxidative DNA Damage and Cisplatin Neurotoxicity Is Exacerbated by Inhibition of OGG1 Glycosylase Activity and APE1 Endonuclease Activity in Sensory NeuronsAdib Behrouzi0Hanyu Xia1Eric L. Thompson2Mark R. Kelley3Jill C. Fehrenbacher4Department of Pharmacology and Toxicology, Indiana University School of Medicine, Indianapolis, IN 46202, USADepartment of Pharmacology and Toxicology, Indiana University School of Medicine, Indianapolis, IN 46202, USADepartment of Pharmacology and Toxicology, Indiana University School of Medicine, Indianapolis, IN 46202, USADepartment of Pharmacology and Toxicology, Indiana University School of Medicine, Indianapolis, IN 46202, USADepartment of Pharmacology and Toxicology, Stark Neuroscience Research Institute, Indiana University Simon Comprehensive Cancer Center, Indiana University School of Medicine, Indianapolis, IN 46202, USACisplatin can induce peripheral neuropathy, which is a common complication of anti-cancer treatment and negatively impacts cancer survivors during and after completion of treatment; therefore, the mechanisms by which cisplatin alters sensory neuronal function to elicit neuropathy are the subject of much investigation. Our previous work suggests that the DNA repair activity of APE1/Ref-1, the rate-limiting enzyme of the base excision repair (BER) pathway, is critical for neuroprotection against cisplatin. A specific role for 8-oxoguanine DNA glycosylase-1 (OGG1), the glycosylase that removes the most common oxidative DNA lesion, and putative coordination of OGG1 with APE1/Ref-1 in sensory neurons, has not been investigated. We investigated whether inhibiting OGG1 glycosylase activity with the small molecule inhibitor, TH5487, and/or APE1/Ref-1 endonuclease activity with APE Repair Inhibitor III would alter the neurotoxic effects of cisplatin in sensory neuronal cultures. Sensory neuron function was assessed by calcitonin gene-related peptide (CGRP) release, as a marker of sensitivity and by neurite outgrowth. Cisplatin altered neuropeptide release in an inverse U-shaped fashion, with low concentrations enhancing and higher concentrations diminishing CGRP release. Pretreatment with BER inhibitors exacerbated the functional effects of cisplatin and enhanced 8oxo-dG and adduct lesions in the presence of cisplatin. Our studies demonstrate that inhibition of OGG1 and APE1 endonuclease activity enhances oxidative DNA damage and exacerbates neurotoxicity, thus limiting oxidative DNA damage in sensory neurons that might alleviate cisplatin-induced neuropathy.https://www.mdpi.com/1422-0067/23/3/1909cisplatinDNA damageoxidative stresschemotherapy-induced peripheral neuropathysensory neuronneuropeptide
spellingShingle Adib Behrouzi
Hanyu Xia
Eric L. Thompson
Mark R. Kelley
Jill C. Fehrenbacher
Oxidative DNA Damage and Cisplatin Neurotoxicity Is Exacerbated by Inhibition of OGG1 Glycosylase Activity and APE1 Endonuclease Activity in Sensory Neurons
International Journal of Molecular Sciences
cisplatin
DNA damage
oxidative stress
chemotherapy-induced peripheral neuropathy
sensory neuron
neuropeptide
title Oxidative DNA Damage and Cisplatin Neurotoxicity Is Exacerbated by Inhibition of OGG1 Glycosylase Activity and APE1 Endonuclease Activity in Sensory Neurons
title_full Oxidative DNA Damage and Cisplatin Neurotoxicity Is Exacerbated by Inhibition of OGG1 Glycosylase Activity and APE1 Endonuclease Activity in Sensory Neurons
title_fullStr Oxidative DNA Damage and Cisplatin Neurotoxicity Is Exacerbated by Inhibition of OGG1 Glycosylase Activity and APE1 Endonuclease Activity in Sensory Neurons
title_full_unstemmed Oxidative DNA Damage and Cisplatin Neurotoxicity Is Exacerbated by Inhibition of OGG1 Glycosylase Activity and APE1 Endonuclease Activity in Sensory Neurons
title_short Oxidative DNA Damage and Cisplatin Neurotoxicity Is Exacerbated by Inhibition of OGG1 Glycosylase Activity and APE1 Endonuclease Activity in Sensory Neurons
title_sort oxidative dna damage and cisplatin neurotoxicity is exacerbated by inhibition of ogg1 glycosylase activity and ape1 endonuclease activity in sensory neurons
topic cisplatin
DNA damage
oxidative stress
chemotherapy-induced peripheral neuropathy
sensory neuron
neuropeptide
url https://www.mdpi.com/1422-0067/23/3/1909
work_keys_str_mv AT adibbehrouzi oxidativednadamageandcisplatinneurotoxicityisexacerbatedbyinhibitionofogg1glycosylaseactivityandape1endonucleaseactivityinsensoryneurons
AT hanyuxia oxidativednadamageandcisplatinneurotoxicityisexacerbatedbyinhibitionofogg1glycosylaseactivityandape1endonucleaseactivityinsensoryneurons
AT ericlthompson oxidativednadamageandcisplatinneurotoxicityisexacerbatedbyinhibitionofogg1glycosylaseactivityandape1endonucleaseactivityinsensoryneurons
AT markrkelley oxidativednadamageandcisplatinneurotoxicityisexacerbatedbyinhibitionofogg1glycosylaseactivityandape1endonucleaseactivityinsensoryneurons
AT jillcfehrenbacher oxidativednadamageandcisplatinneurotoxicityisexacerbatedbyinhibitionofogg1glycosylaseactivityandape1endonucleaseactivityinsensoryneurons